E Fund Management Co., Ltd. Biotechnology

E Fund Management Co., Ltd.

$2.07 Billion
Q1 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
ARWR Arrowhead Pharmaceuticals, Inc.	$1.97B	$229,000 0.01% of portfolio	18,017	Q1 2025 New
BEAM Beam Therapeutics Inc.	$1.49B	$218,000 0.01% of portfolio	11,203	Q1 2025 New
MIRM Mirum Pharmaceuticals, Inc.	$1.85B	$218,000 0.01% of portfolio	4,847	Q1 2025 New
PTGX Protagonist Therapeutics, Inc	$2.45B	$200,000 0.01% of portfolio	4,137	Q1 2025 Reduced 94.56%
SNDX Syndax Pharmaceuticals Inc	$557M	$197,000 0.01% of portfolio	16,031	Q1 2025 Added 27.2%
FOLD Amicus Therapeutics, Inc.	$1.75B	$193,000 0.01% of portfolio	23,716	Q1 2025 Added 0.09%
IDYA Ideaya Biosciences, Inc.	$1.02B	$185,000 0.01% of portfolio	11,344	Q1 2025 Added 35.63%
CLDX Celldex Therapeutics, Inc.	$1.09B	$183,000 0.01% of portfolio	10,125	Q1 2025 Reduced 6.12%
ARDX Ardelyx, Inc.	$693M	$180,000 0.01% of portfolio	36,768	Q1 2025 Reduced 2.8%
BCRX Biocryst Pharmaceuticals Inc	$1.67B	$177,000 0.01% of portfolio	23,674	Q1 2025 Added 42.51%
NVAX Novavax Inc	$545M	$166,000 0.01% of portfolio	25,954	Q1 2025 Added 2.42%
DNLI Denali Therapeutics Inc.	$1.97B	$164,000 0.01% of portfolio	12,069	Q1 2025 Added 20.73%
DYN Dyne Therapeutics, Inc.	$423M	$144,000 0.01% of portfolio	13,771	Q1 2025 Added 16.23%
IOVA Iovance Biotherapeutics, Inc.	$317M	$131,000 0.01% of portfolio	39,394	Q1 2025 Reduced 0.11%
GERN Geron Corp	$518M	$130,000 0.01% of portfolio	82,389	Q1 2025 Reduced 3.68%
MNKD Mannkind Corp	$1.04B	$124,000 0.01% of portfolio	24,667	Q1 2025 Added 11.92%
NRIX Nurix Therapeutics, Inc.	$583M	$122,000 0.01% of portfolio	10,288	Q1 2025 New
NTLA Intellia Therapeutics, Inc.	$908M	$119,000 0.01% of portfolio	16,831	Q1 2025 Reduced 6.77%
VIR Vir Biotechnology, Inc.	$730M	$103,000 0.0% of portfolio	15,993	Q1 2025 New
AVXL Anavex Life Sciences Corp.	$779M	$102,000 0.0% of portfolio	11,911	Q1 2025 New
RCKT Rocket Pharmaceuticals, Inc.	$231M	$97,000 0.0% of portfolio	14,567	Q1 2025 Added 31.78%
ETNB 89bio, Inc.	$471M	$93,000 0.0% of portfolio	12,827	Q1 2025 New
COGT Cogent Biosciences, Inc.	$615M	$93,000 0.0% of portfolio	15,670	Q1 2025 Added 37.7%
IBRX Immunity Bio, Inc.	$1.16B	$91,000 0.0% of portfolio	30,331	Q1 2025 Reduced 22.03%
DAWN Day One Biopharmaceuticals, Inc.	$509M	$88,000 0.0% of portfolio	11,136	Q1 2025 Reduced 1.24%
RCUS Arcus Biosciences, Inc.	$696M	$82,000 0.0% of portfolio	10,498	Q1 2025 New
KURA Kura Oncology, Inc.	$425M	$80,000 0.0% of portfolio	12,252	Q1 2025 Added 18.94%
ALT Altimmune, Inc.	$217M	$67,000 0.0% of portfolio	13,427	Q1 2025 Added 20.32%
RLAY Relay Therapeutics, Inc.	$428M	$50,000 0.0% of portfolio	19,165	Q1 2025 Added 8.56%
VERV Verve Therapeutics, Inc.	$669M	$48,000 0.0% of portfolio	10,522	Q1 2025 New
AKBA Akebia Therapeutics, Inc.	$678M	$37,000 0.0% of portfolio	19,311	Q1 2025 Added 51.86%
SANA Sana Biotechnology, Inc.	$803M	$30,000 0.0% of portfolio	18,236	Q1 2025 Reduced 17.86%
HUMA Humacyte, Inc.	$249M	$29,000 0.0% of portfolio	17,133	Q1 2025 Added 4.82%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of E Fund Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on E Fund Management Co., Ltd. with notifications on news.